Abstract GS3-04: A randomized phase III study of adjuvant trastuzumab for a duration of 9 weeks versus 1 year, combined with adjuvant taxane-anthracycline chemotherapy, for early HER2-positive breast cancer (the SOLD study)

Joensuu, Heikki (author)

Fraser, Judith (author)

Wildiers, Hans (author)

show more...

Huovinen, Riikka (author)

Auvinen, Paivi (author)

Utriainen, Meri (author)

Nyandoto, Paul (author)

Villman, Kenneth K. (author)

Halonen, Paivi (author)

Granstam Björneklett, Helena, 1962- (author)

Uppsala universitet,Centrum för klinisk forskning, Västerås,Västerås Central Hospital, Västerås, Sweden

Lundgren, Lotta (author)

Yachnin, Jeffrey (author)

Turpeenniemi-Hujanen, Taina (author)

Ritchie, Diana (author)

Huttunen, Teppo (author)

Neven, Patric (author)

Canney, Peter (author)

Harvey, Vernon J. (author)

Kellokumpu-Lehtinen, Pirkko-Liisa (author)

Lindman, Henrik (author)

Uppsala universitet,Experimentell och klinisk onkologi

show less...

 (creator_code:org_t)

2018

2018

English.

In: Cancer Research. - 0008-5472 .- 1538-7445. ; 78:4

Related links:

https://urn.kb.se/re...

show more...

https://doi.org/10.1...

show less...

• Journal article (other academic/artistic)